Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

213 Views

Poster Session: Antimicrobial Novel Agents

1689 - In Vitro Activity of Lefamulin Against Bacterial Pathogens Collected From Pneumonia Patients in United States and Latin America Medical Centers in 2020-2021

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Co-Author(s)

SP

Susanne Paukner, PhD

Vice President Microbiology
Nabriva Therapeutics
Vienna, Wien, Austria
SA

SJ Ryan Arends, PhD

Principal Scientist
JMI Laboratories
North Liberty, Iowa, United States
RM

Rodrigo E. Mendes, PhD

Director of Microbiology & Molecular Biology
JMI Laboratories
North Liberty, Iowa, United States
Steven P. Gelone, PharmD

President & Chief Operating Officer
Nabriva Therapeutics
Fort Washington, Pennsylvania, United States

Presenting Author(s)

Helio S. Sader, MD, PhD

Senior Director, Microbiology & Surveillance
JMI Laboratories
North Liberty, Iowa, United States